Chairman and Chief Executive Officer Liang Wenqing increased his shareholding in CF PHARMTECH (02652) by 19,300 shares at approximately HK$6.92 per share.
On October 6, Chairman and Chief Executive Officer Liang Wenqing increased his shareholding in CF PHARMTECH (02652) by 19,300 shares at HK$6.9216 per share, for a total amount of approximately HK$133,600.
The latest data from the Hong Kong Stock Exchange shows that on October 6, Chairman and Chief Executive Officer Liang Wenqing increased his shareholding in CF PHARMTECH (02652) by 19,300 shares at HK$6.9216 per share, for a total amount of approximately HK$133,600. After the increase, his latest shareholding stood at approximately 60,716,500 shares, representing an 18.74% stake.
Supplementary information: Pursuant to Acting-in-Concert Agreement, Dr. LIANG Bill Wenqing and Dr. LI LI BOVET are parties acting in concert. As such, under the SFO, each of Dr. LIANG and Dr. LI LI BOVET is deemed to be interested in the Shares the other is interested in.
Related Articles
EDGE MEDICAL-B (02675) repurchased 255,900 shares on October 9 for approximately HK$8.3868 million.
Soho Holly Corporation (600128.SH) plans to sell no more than 4.4 million A-shares of Soho Holly Futures.
MIKO INTL (01247): Liu Min Appointed as Authorized Representative
EDGE MEDICAL-B (02675) repurchased 255,900 shares on October 9 for approximately HK$8.3868 million.
Soho Holly Corporation (600128.SH) plans to sell no more than 4.4 million A-shares of Soho Holly Futures.
MIKO INTL (01247): Liu Min Appointed as Authorized Representative
